Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON39439
NL-OMON39439
Recruiting
Phase 3

Value of multiparametric MR and MRI-guided biopsies of the prostate in men with an elevated PSA - Value of MRI in diagnosing prostate cancer

niversitair Medisch Centrum Sint Radboud0 sites620 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprostate cancerprostatic carcinoma1001471310036958

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
prostate cancer
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
620
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •Men, 50\-75 years, PSA \> 3 ng/ml

Exclusion Criteria

  • •Use of 5\-alfareductase inhibitors
  • •Proven prostate cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Met prostaat MRI Meer MansProstate cancer, molecular urine test, mri prostate, mri guided biopsy, prostate risc calculator, PSA, TRUS biopsyDutch: Prostaatkanker, moleculaire biomarker, prostaat risico calculator, MRI, MRI geleide biopsie, echo gelede transrectale biopsie, PSA
NL-OMON22730Radboudumc660
Completed
Phase 2
A study looking at the use of multiparametric Magnetic Resonance Imaging (MRI) and Positron Emission Tomography - Computed Tomography (PET-CT) to evaluate radiological changes after lung stereotactic ablative radiotherapy (SABR).on small cell lung cancer (NSCLC)Oligometastatic disease involving lungNon small cell lung cancer (NSCLC)Cancer - Lung - Non small cellCancer - Other cancer types
ACTRN12616000801415iverpool Hospital23
Not yet recruiting
Not Applicable
MR biopsy versus MR guided ultrasound fusion biopsy in prostate cancer diagnosisProstate cancerProstate carcinoma1002765610036958
NL-OMON38691niversitair Medisch Centrum Sint Radboud50
Completed
Not Applicable
Multiparametric Magnetic Resonance Imaging (MRI) as an Outcome Predictor for Anal Canal Cancer Managed with ChemoradiotherapyAnal CancerCancer - Bowel - Anal
ACTRN12614001219673Dr Michael Jones20
Recruiting
Not Applicable
Multi-parametric MRI for Therapeutic Response Prediction in Rectal CancerRectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12616001690448Dr Trang Pham35